United States Obesity Market Analysis and Competitive Landscape Report 2022
Dublin, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The "US Obesity Market and Competitive Landscape - 2022" report has been added to ResearchAndMarkets.com's offering.
The report provides comprehensive insights into Obesity pipeline products, Obesity epidemiology, Obesity market valuations and forecast, Obesity drugs sales and competitive landscape in the US.
The research is classified into seven sections - Obesity treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.
Obesity pipeline: Find out the products in clinical trials for the treatment of Obesity by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
Obesity epidemiology: Find out the number of patients diagnosed (prevalence) with Obesity in the US
Obesity drugs: Identify key products marketed and prescribed for Obesity in the US, including trade name, molecule name, and company
Obesity drugs sales: Find out the sales revenues of Obesity drugs in the US
Obesity market valuations: Find out the market size for Obesity drugs in 2021 in the US. Find out how the market advanced from 2019 and forecast to 2027
Obesity drugs market share: Find out the market shares for key Obesity drugs in the US
Benefits of this Research:
Support monitoring and reporting national Obesity market analysis and sales trends
Track competitor drugs sales and market share in the US Obesity market
Track competitive developments in Obesity market and present key issues and learnings
Synthesize insights for Obesity market and products to drive business performance
Answer key business questions about the Obesity market
Evaluate commercial market opportunity assessment, positioning, and segmentation for Obesity products
Supports decision making in R&D to long term marketing strategies
List of Tables
1. Obesity Phase 3 Clinical Trials, 2022
2. Obesity Phase 2 Clinical Trials, 2022
3. Obesity Phase 1 Clinical Trials, 2022
4. Obesity Epidemiology, US, 2021 - 2027
5. Marketed Drugs for Obesity, US, 2021
6. Obesity Market Size and Forecast ($), US, 2019 - 2027
7. Obesity Drugs Sales ($), US, 2019 - 2027
List of Figures
1. Obesity Epidemiology, US, 2021 - 2027
2. Obesity Market Size and Forecast ($), US, 2019 - 2027
3. Obesity Drugs Market Share (%), US, 2021
For more information about this report visit https://www.researchandmarkets.com/r/jrv5f3-obesity-market?w=12
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900